Search results
Stephens Inc. AR Has $1.78 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 5 hours agoStephens Inc. AR increased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 18.3% in the 4th quarter, according to its most recent disclosure with the ...
Deutsche Bank maintains 'Hold' on AstraZeneca post ASCO conference By Investing.com
Investing.com· 4 days agoOn Monday, Deutsche Bank (ETR:DBKGn) reiterated a Hold rating and a price target of GBP110.00 on ...
AstraZeneca Buy rating, stock target reiterated on consistent presence By Investing.com
Investing.com· 4 days agoOn Wednesday, Citi reaffirmed its Buy rating on AstraZeneca (NASDAQ:AZN) shares with a steady price ...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 4 days agoThe conference was a big one for Summit Therapeutics, which saw its stock price more than double...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 2 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 6 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
Move over 'Magnificent 7,' the 'Fantastic 5' may offer higher earnings and return potential
CNBC· 3 days agoLooking for a less risky way to find growth stocks amid all the artificial intelligence hype?...
Head-To-Head Survey: Ionis Pharmaceuticals (NASDAQ:IONS) versus Nurix Therapeutics (NASDAQ:NRIX)
ETF DAILY NEWS· 4 days agoNurix Therapeutics (NASDAQ:NRIX – Get Free Report) and Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) are both medical companies, but which is the better stock? We ...
Economic Worries May Lead To Weakness On Wall Street
RTT News· 5 days agoThe major U.S. index futures are currently pointing to a lower open on Tuesday, with stocks likely to move to the downside following the mixed performance seen in the previous session. Concerns ...